离子交换与吸附

参考文献

[1] Kresge C T, Leonowicz M E, Roth W J, et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism[J]. Nature, 1992, 359(6397):710-712.

[2] Dhaneswara D, Fatriansyah J F, Mahagnyana A B, et al. The role of modification SBA-15 mesoporous silica with CPTMS in Cd adsorptions[J]. IOP Conference Series:Materials Science and Engineering, 2018,299(1):12063-12072.

[3] Ortíz-Martínez K, Valentin D V, Hernandez-Maldonado A J. Adsorption of contaminants of emerging concern from aqueous solutions using Cu2+amino grafted SBA-15 mesoporous silica:Multi-component and metabolites adsorption[J]. Industrial&Engineering Chemistry Research, 2018, 57(18):6426-6439.

[4] Wang Z, Xu C, Lu Y, et al. Visualization of adsorption:luminescent mesoporous silica-carbon dots composite for rapid and selective removal of U(VI)and in situ monitoring the adsorption behavior[J]. Acs Applied Materials&Interfaces, 2017, 9(8):7392-7398.

[5] Zhao Y, Zhang Y, Wang Y, et al. Structure evolution of mesoporous silica supported copper catalyst for dimethyl oxalate hydrogenation[J]. Applied Catalysis A:General, 2017, 539:59-69.

[6] Almeida T S D, Guima K E, Silveira R M, et al. A Pd nanocatalyst supported on multifaceted mesoporous silica with enhanced activity and stability for glycerol electrooxidation[J]. Rsc Advances, 2017, 7(20):12006-12016.

[7] Freitas L B D O, Corgosinho L D M, Santos V M D, et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted, controlled drug delivery and imaging[J]. Microporous and Mesoporous Materials, 2017,242:271-283.

[8] Nairi V, Magnolia S, Piludu M, et al. Mesoporous silica nanoparticles functionalized with hyaluronic acid.Effect of the biopolymer chain length on cell internalization[J]. Colloids and Surfaces B:Biointerfaces,2018, 168:50-59.

[9] Yan X, Chen J, Xue Q, et al. Synthesis and magnetic properties of CoFe2O4, nanoparticles confined within mesoporous silica[J]. Microporous and Mesoporous Materials, 2018, 135(1):137-142.

[10] Wang T, Liu Y, Wu C. Effect of paclitaxel-mesoporous silica nanoparticles with a core-shell structure on the human lung cancer cell line A549[J]. Nanoscale Research Letters, 2017, 12(1):66-74.

[11] Saroj S, Rajput S J. Etoposide encapsulated functionalized mesoporous silica nanoparticles:Synthesis,characterization and effect of functionalization on dissolution kinetics in simulated and biorelevant media[J].Journal of Drug Delivery Science and Technology, 2018, 44:27-40.

[12] Tahmasbi L, Sedaghat T, Motamedi H, et al. Mesoporous silica nanoparticles supported copper(II)and nickel(II)Schiff base complexes:Synthesis, characterization, antibacterial activity and enzyme immobilization[J]. Journal of Solid State Chemistry, 2018, 258:517-525.

[13] Li Z, Clemens D L, Lee B Y, et al. Mesoporous silica nanoparticles with pH-Sensitive nanovalves for delivery of moxifloxacin provide improved treatment of lethal pneumonic tularemia[J]. Acs Nano, 2015,9(11):10778-10789.

[14] Bai L, Zhao Q, Wang J, et al. Mechanism study on pH-responsive cyclodextrin capped mesoporous silica:Effect of different stalk densities and the type of cyclodextrin[J]. Nanotechnology, 2015, 26(16):165704-165714.

[15] Zhou J, Li M, Wei Q L, et al. A transferrin-conjugated hollow nanoplatform for redox-controlled and targeted chemotherapy of tumor with reduced inflammatory reactions[J]. Theranostics, 2018, 8(2):518-532.

[16] Giménez C, De l T C, Gorbe M, et al. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells[J]. Langmuir, 2015, 31(12):3753-3762.

[17] Lin J T, Liu Z K, Zhu Q L, et al. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles[J]. Colloids and Surfaces B Biointerfaces,2017, 155:41-50.

[18] Zhao Y L, Li Z, Kabehie S, et al. pH-Operated nanopistons on the surfaces of mesoporous silica nanoparticles[J]. Journal of the American Chemical Society, 2010, 132(37):13016-13025.

[19] Chen Y, Ai K, Liu J, et al. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging[J]. Biomaterials, 2015, 60(1):111-120.

[20]édgar Pérez-Esteve, Fuentes A, Coll C, et al. Modulation of folic acid bioaccessibility by encapsulation in pH-responsive gated mesoporous silica particles[J]. Microporous and Mesoporous Materials, 2015, 202:124-132.

[21] Wei Y, Gao L, Wang L, et al. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy[J]. Drug Delivery, 2017, 24(1):681-691.

[22] Roik N V, Belyakova L A. Mesoporous silica nanoparticles equipped with surface nanovalves for pH-controlled liberation of doxorubicin[J]. Interface Focus, 2016, 6(6):20160041.

[23] Meng H, Xue M, Xia T, et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves[J]. Journal of the American Chemical Society, 2010, 132(36):12690-12697.

[24] Giménez C, Gorbe M, et al. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells[J]. Langmuir, 2015, 31(12):3753-3762.

[25] Li H, Liu Y, Chen L, et al. Folate receptor-targeted lipid-albumin nanoparticles(F-LAN)for therapeutic delivery of an antisense oligonucleotide[J]. Journal of Drug Targeting, 2018, 26(5/6):466-473.

[26] Zhang Q, Liu F, Nguyen K T, et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery[J]. Advanced Functional Materials, 2015, 22(24):5144-5156.

[27] Yang T, Xu F, Zhao Y, et al. A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer[J]. Proteomics Clinical Applications, 2014, 8(9/10):773-782.

[28] Li D, Tu T, Yang M, et al. Efficient preparation of surface imprinted magnetic nanoparticles using poly(2-anilinoethanol)as imprinting coating for the selective recognition of glycoprotein[J]. Talanta, 2018, 184:316-324.

[29] Chen X, Sun H, Hu J, et al. Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery[J]. Colloids and Surfaces B:Biointerfaces, 2017, 152:77-84.

[30] Lv G, Li K, Qiu L, et al. Enhanced tumor diagnostic and therapeutic effect of mesoporous silica nanoparticle-mediated pre-targeted strategy[J]. Pharmaceutical Research, 2018, 35(3):63-73.

[31] De l T C, Domínguez-Berrocal L, Murguía J R, et al.ε-polylysine-capped mesoporous silica nanoparticles as carrier of the C9h peptide to induce apoptosis in cancer cells[J]. Chemistry-A European Journal, 2018,24(8):1890-1897.

[32] Li J, Liu F, Shao Q, et al. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells[J]. Advanced Healthcare Materials, 2014, 3(8):1230-1239.

[33] Aznar E, Villalonga R, Marcos M D. Glucose-triggered release using enzyme-gated mesoporous silica nanoparticles[J]. Chemical Communications, 2013, 49(57):6391-6393.

[34] Liu J, Li Q, Zhang J, et al. Safe and effective reversal of cancer multidrug resistance using sericin-coated mesoporous silica nanoparticles for lysosome-targeting delivery in mice[J]. Small, 2017, 13(9):160-174.

[35] Teruel A H, Coll C, Costero A M, et al. Functional magnetic mesoporous silica microparticles capped with an Azo-derivative:A promising colon drug delivery device[J]. Molecules, 2018, 23(2):375-387.

[36] Zhao J, He Z, Li B, et al. AND logic-like pH-and light-dual controlled drug delivery by surface modified mesoporous silica nanoparticles[J]. Materials Science and Engineering C, 2017, 73:1-7.

[37] Mal N K, Fujiwara M, Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica[J]. Nature, 2003, 421(6921):350-353.

[38] Chai S, Guo Y, Zhang Z, et al. Cyclodextrin-gated mesoporous silica nanoparticles as drug carriers for red light-induced drug release[J]. Nanotechnology, 2017, 28(14):1-10.

[39] Karthik S, Jana A, Saha B, et al. Synthesis and in vitro evaluation of charge reversal photoresponsive quinoline tethered mesoporous silica for targeted drug delivery[J]. Journal of Materials Chemistry B, 2014,2(45):7971-7977.

[40] Yao X, Niu X, Ma K, et al. Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy[J].Small, 2017, 13(2):1-11.

[41] Lu F, Popa A, Zhou S, et al. Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia[J]. Chemical Communications, 2013, 49(97):11436-11438.

[42] Chen W H, Luo G F, Qiu W X, et al. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy[J]. Biomaterials, 2017,117:54-65.

[43] Zhou S, Wu D, Yin X, et al. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells[J]. Journal of Experimental&Clinical Cancer Research, 2017, 36(1):1-14.

[44] Chen C, Sun W, Wang X, et al. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery[J]. International Journal of Biological Macromolecules, 2018, 111:1106-1115.